Personalized medicine and antiplatelet therapy: ready for prime time?

Abstract

Division of Clinical Pharmacology, Department of Medicine, University of Western Ontario, 339 Windermere Road, London, Ontario, Canada N6A 5A5; Pharmacology Department, Univ Paris Sud, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), 78 rue du General Leclerc, 94275 Le Kremlin Bicêtre, France; and Pharmacology Department, Assistance Publique—Hopitaux de Paris (AP-HP, site St Antoine) URC-EST, Universite Pierre et Marie Curie (UPMC)-Paris 06, 27 rue de Chaligny, 75012 Paris, France

DOI: 10.1093/eurheartj/ehp295

10 Figures and Tables

Statistics

020406020102011201220132014201520162017
Citations per Year

70 Citations

Semantic Scholar estimates that this publication has 70 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Verstuyft2009PersonalizedMA, title={Personalized medicine and antiplatelet therapy: ready for prime time?}, author={C{\'e}line Verstuyft and Tabassome Simon and Richard B Kim}, journal={European heart journal}, year={2009}, volume={30 16}, pages={1943-63} }